Searched for
PETER BAINS SYNGENE
Syngene shares zoom 17% even as firm’s Q4 net profit drops 19% YoY. What's driving the surge?Syngene shares surged despite a 19% YoY decline in Q4FY26 net profit to Rs 148 crore, as earnings rebounded sharply from Rs 15 crore in the...- Syngene expands research collaboration with Bristol Myers SquibbSyngene International has extended its research partnership with Bristol Myers Squibb until 2035. This expanded agreement covers more servi...
- Syngene International reports 11% revenue growth and 59% net profit surge in Q1Syngene International, a Biocon subsidiary, reveals an 11% revenue increase to Rs 875 crore for the first quarter. Net profit jumps 59% to ...
- China’s India headache: The growing pharmaceutical industryIndian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring trend and a desir...
- Syngene International shares slump 10% after Q4 profit dips despite revenue growthSyngene International's shares plummeted 10% following a reported 3% year-on-year decline in consolidated net profit for Q4 FY25, despite a...
- Syngene Q4 Results: Profit dips 3% to Rs 183 crore; FY25 net at Rs 496 crContract research and manufacturing services firm Syngene International on Wednesday reported a 3 per cent dip in consolidated net profit a...
- India's contract drug makers seek government support in China fightIndia's contract drug makers are seeking government support to remove regulatory hurdles and speed up raw material import clearances. With ...
- Syngene's MD & CEO Jonathan Hunt steps down, Peter Bains named as new CEOJonathan Hunt has stepped down as the managing director and CEO of Syngene International, with Peter Bains appointed as the CEO Designate e...
- 'Biocon looking at options to cut debt taken for Viatris' business buy'"We are looking at a number of options to reduce that... I can say that you'll see the debt level coming down in the coming quarters," he s...
- New Group CEO is someone who understands Biocon's business synergy well: Kiran Mazumdar-Shaw"Peter, who is a veteran when it comes to the pharma and biopharma industry in terms of his global experience, also understands the Biocon ...
- Biocon appoints Peter Bains as Group CEO"I am delighted to welcome Peter to the Biocon Group in the role of Group CEO. Siddharth Mittal, CEO & MD Biocon Limited, Shreehas Tambe, C...
- Syngene International Q3 net profit up 31% at Rs 59 croreSyngene International has reported a 31.25 per cent rise in its net profit to Rs 58.8 crore for the third quarter ended December 31.
- Syngene Q3 net up 31% to Rs 59 croreBiocon's contract research arm Syngene International reported 31.25% rise in net profit to Rs 58.8 crore for the third quarter of 2015-16 f...
- Syngene appoints Jonathan Hunt as CEO-designateHunt will take charge after the retirement of current CEO Peter Bains in March, Syngene International said in a regulatory filing.
- Syngene Q2 net profit rises 31% to Rs 52 croreSyngene International, research arm of Biocon, today posted 30.69 per cent rise in its net profit at Rs 52.29 crore for the second quarter ...
- Syngene gets FIPB nod to raise foreign investment to 44%Syngene, a subsidiary of Biocon, said it has received the Foreign Investment Promotion Board approval to raise foreign investment to 44 per...
- Biocon arm Syngene appoints Peter Bains as CEOBains has been a director of Syngene, since 2011. Syngene had yesterday said it would set up a new plant at Mangalore SEZ to manufacture ph...
- Biocon’s unit extends partnership with US-based Bristol-Myers SquibbThe two cos announced to renew their engagement, boosted by encouraging results in last 5 years, during when 6 drug molecules have been bro...
- Biocon unit inks pact with US firm to expand collaborationBiotech firm Biocon today said its subsidiary 'Syngene International' has entered into an agreement with US-based Endo Pharmaceuticals to e...
Load More
